Clinical Trials Directory

Trials / Completed

CompletedNCT02918461

Emerging From the Haze for Gynecologic Cancer Survivors

A Pilot Study of Emerging From the Haze Evaluating a Trainee-taught Psycho-educational Program to Improve Cancer-related Cognitive Complaints in Gynecologic Cancer Survivors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Cedars-Sinai Medical Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

At Cedars-Sinai Medical Center, the investigators have developed a novel curriculum for a 6-week psycho-educationally-based, cognitive behavioral program to help patients with subjective cognitive complaints after cancer treatment, titled Emerging from the Haze™ (Haze). Each series meets once a week for 2-2.5 hours for 6 weeks. The objective of this study is to quantify the impact of a trainee-taught Emerging from the Haze course on gynecologic cancer survivors' self-report of cognitive changes based on the change of FACT-Cog score.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEmerging from the Haze classA 6-week class designed to combat chemotherapy-induced cognitive dysfunction. Patients will report symptoms at 6 months and 1 year after the end of their Haze class.

Timeline

Start date
2017-01-10
Primary completion
2017-05-01
Completion
2017-11-01
First posted
2016-09-29
Last updated
2019-01-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02918461. Inclusion in this directory is not an endorsement.

Emerging From the Haze for Gynecologic Cancer Survivors (NCT02918461) · Clinical Trials Directory